Skip to main content

Tazarotene News

FDA Approves Arazlo (tazarotene) Lotion for the Topical Treatment of Acne Vulgaris

BRIDGEWATER, N.J., Dec. 19, 2019 /PRNewswire/ – Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health...

FDA Approves Duobrii (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis In Adults

LAVAL, Quebec, April 25, 2019 /PRNewswire/ – Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care...

Stiefel Receives US FDA Approval of Fabior Foam, 0.1%

RESEARCH TRIANGLE PARK, N.C., May 11, 2012 /PRNewswire/ – Stiefel, a GSK (NYSE: GSK) company, today announced that the US Food and Drug Administration has approved the New Drug Application for...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Plaque Psoriasis, Acne, Psoriasis

Tazarotene patient information at Drugs.com